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Although pregnancy confers unique susceptibility to
infection, the pregnancy-associated immune defects
that erode host defense remain largely undefined.
Herein, we demonstrate that expansion of immune-
suppressive Foxp3+ regulatory T cells (Tregs) which
occurs physiologically during pregnancy or when
experimentally induced in transgenic mice caused
enhanced susceptibility to prenatal pathogens in-
cluding Listeria and Salmonella species. Recipro-
cally, infection susceptibility was uniformly reduced
with Treg ablation. Importantly however, the sus-
tained expansion of maternal Tregs was essential
for maintaining immune tolerance to the developing
fetus because even partial transient ablation of
Foxp3-expressing cells fractured maternal tolerance
to fetal antigen and triggered fetal resorption. Inter-
estingly, Foxp3 cell-intrinsic defects in the immune-
suppressive cytokine IL-10 alone were sufficient
to override Treg-mediated infection susceptibility,
while IL-10 was nonessential for sustaining preg-
nancy. Thus, maternal Treg expansion required for
sustaining pregnancy creates naturally occurring
holes in host defense that confer prenatal infection
susceptibility.
INTRODUCTION
The pregnancy-associated susceptibility to intracellular patho-
gens has been classically attributed to a shift in helper T cell
differentiation from a Th1- to Th2-dominated response required
for maintaining pregnancy (Krishnan et al., 1996; Piccinni et al.,
1998; Wegmann et al., 1993). However, the more recent identifi-
cation of other distinct CD4+ T cell lineages has blurred the
dichotomy between Th2 responses that sustain pregnancy and
Th1 cells that promote rejection of the developing fetus by acti-
vating cellular immunity (Saito et al., 2010). These include Th1754 Cell Host & Microbe 10, 54–64, July 21, 2011 ª2011 Elsevier Inc.cells that provide protection against extracellular pathogens by
promoting inflammation, and immune-suppressive regulatory
T cells (Tregs) that maintain peripheral tolerance by restraining
the activation of self-reactive immune cells (Curtis and Way,
2009; Littman and Rudensky, 2010). In parallel with the identifi-
cation of these additional T cell subsets, the requirement for
expanded immune tolerance during pregnancy has become
more specifically linked with the expansion of maternal Tregs.
For example, circulating maternal Foxp3+ Tregs expand and
peak midgestation to approximately 50% increased levels in
human pregnancy (Santner-Nanan et al., 2009; Somerset et al.,
2004). Reciprocally, defects in Treg expansion are associated
with specific pregnancy complications such as preeclampsia
or spontaneous abortion, each related to maternal intolerance
to the developing fetus (Prins et al., 2009; Santner-Nanan
et al., 2009; Sasaki et al., 2004).
This association between maternal Tregs and pregnancy
outcomes has also been experimentally explored in mouse
models in which CD25+CD4+ cells are required for maintaining
healthy pregnancy (Aluvihare et al., 2004; Kahn and Baltimore,
2010). However, since previously employed approaches that
cause the near-complete ablation of these cells do not allow
the importance of expanded Tregs from steady-state prepreg-
nancy levels in sustaining pregnancy to be addressed, and
CD25 expression does not discriminate between bona fide Tregs
and activated T cells, the actual requirement for expanded
maternal Foxp3+ Tregs during pregnancy remains undefined.
More importantly, given the fluid balance between immune
suppression and stimulation controlled by Tregs, the expansion
of Foxp3+ cells during pregnancy may also create holes in host
defense that confer susceptibility to pathogens with a predilec-
tion for prenatal infection. In this regard, while the effects of
Treg ablation on infection susceptibility have been investigated
in numerous models of parasitic, bacterial, fungal, and viral
infection (Belkaid, 2007; Suvas and Rouse, 2006), the impacts
on host defense resulting from themore physiological expansion
of these cells have not been described.
Foxp3+ Tregs can use numerous molecules to mediate
context-specific immune suppression (Sakaguchi et al., 2009;
Shevach, 2009; Vignali et al., 2008). For example, Tregs are en-
riched for CTLA-4 expression, and sustained CTLA-4 ablation in
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Expanded Tregs Dictate Susceptibility to InfectionFoxp3+ cells causes nonspecific T cell activation and systemic
autoimmunity (Friedline et al., 2009; Wing et al., 2008). Interest-
ingly, while CTLA-4 ablation in Foxp3+ cells reproduces some
features of Treg deficiency, it does not recapitulate the more
rapid onset of fatal systemic autoimmunity in mice with naturally
occurring or targeted defects in all Tregs due to Foxp3 deficiency
(Fontenot et al., 2003; Khattri et al., 2003). Comparatively, abla-
tion of IL-10 in Foxp3+ Tregs results in minimal systemic autoim-
munity but instead causes inflammation limited to sites with
contact to the external environment (Rubtsov et al., 2008). This
discordance in phenotype after sustained ablation of specific
molecules in Foxp3-expressing cells illustrates unique, nonover-
lapping, and specialized roles for individual Treg-expressed
molecules. Accordingly, identifying how Foxp3+ cells mediate
suppression in each context opens up the exciting possibility
of dissociating the beneficial and harmful impacts of Tregs.
Specifically, given the parallels between maternal Treg expan-
sion and healthy uncomplicated pregnancy, together with the
detrimental role Tregs play in host defense against infection,
dissociating the Treg-associated molecules required for each
may unlock therapeutic approaches that boost immunity against
infection without compromising immune tolerance required for
sustaining pregnancy.
To address these questions, we established a pregnancy
model using mice with divergent MHC that recapitulates the
natural variation between maternal and fetal antigen, and
progressive expansion of maternal Foxp3+ Tregs during human
pregnancy. Using this model, we demonstrate that maternal
Tregs impair host defense, causing susceptibility to pathogens
including Listeria and Salmonella species with a defined predi-
lection for prenatal infection. In turn, the sustained expansion
of maternal Foxp3+ Tregs was also essential for maintaining
healthy pregnancy, because even partial transient ablation
to levels found in nonpregnant controls triggered sharply
increased rates of fetal resorption and fractured tolerance to fetal
antigen. Using mice containing Tregs with targeted defects in
defined molecules implicated in suppression, we further demon-
strate an essential role for Treg IL-10 in suppressing host
defense against infection, while maternal IL-10 is nonessential
for maintaining pregnancy. These results illustrate naturally
occurring holes in host defense associated with physiological
shifts in maternal Tregs, and identify Treg-associated molecules
that dissociate the detrimental impacts of expanded Tregs on
infection susceptibility from those required for sustaining
pregnancy.
RESULTS
Expanded Maternal Foxp3+ Tregs Dictate Infection
Susceptibility during Pregnancy
To reproduce the heterogeneity betweenmaternal and fetal anti-
gens during human pregnancy, we established synchronized
matings between MHC mismatched strains of inbred mice
(Balb/c H-2d males with B6 H-2b females) that more fully recapit-
ulate the expanded repertoire of nonself fetal antigen encoun-
tered by the maternal immune system. In this model, Foxp3+
Tregs expand in a synchronized fashion to 50% increased
levels by midgestation compared with nonpregnant controls or
after syngeneic mating (Figure 1A). This magnitude of maternalCTreg expansion is consistent with that reported in human and
other models of mouse allogeneic pregnancy, and increased
compared with syngeneic pregnancy where the only source of
antigen heterogeneity are those encoded by the Y chromosome
(Aluvihare et al., 2004; Santner-Nanan et al., 2009; Somerset
et al., 2004). Interestingly, the expansion of maternal Tregs is
not due to IFN-g production against the allogeneic fetus,
because Foxp3+ cell expansion is primed to a similar magnitude
in IFN-g receptor-deficient mice (12.2% ± 0.3% Foxp3+ cells in
nonpregnant compared with 17.0% ± 0.6% at midgestation).
These direct parallels between the magnitude of maternal
Foxp3+ cell expansion and the degree of heterogeneity between
maternal and fetal antigen suggest expanded Tregs play an
important role in maintaining immune tolerance to the devel-
oping fetus during pregnancy.
Given the pivotal role Foxp3+ Tregs play in controlling the
balance between immune suppression that maintains peripheral
tolerance and immune activation required for optimal host
defense against infection (Belkaid, 2007; Suvas and Rouse,
2006), we speculated the expansion of immune-suppressive
Tregs during pregnancy may also confer susceptibility to infec-
tion. In turn, this host defense defect would likely be exploited
by pathogens that have a defined predisposition for infection
during pregnancy. Among human pathogens, the intracellular
bacterium Listeria monocytogenes (Lm) has a striking predilec-
tion for disseminated infection in pregnant women (Gellin
et al., 1991; Mylonakis et al., 2002). Consistent with these epide-
miological features, pregnant mice at midgestation compared
with nonpregnant controls were markedly more susceptible to
Lm infection (Figure 1B). To investigate the contribution of
maternal Tregs on infection susceptibility, female Foxp3DTR
mice on the B6 background were substituted for mating with
Balb/c males. These transgenic mice coexpress with Foxp3
the high-affinity human diphtheria toxin (DT) receptor allowing
targeted ablation of maternal Foxp3-expressing cells with low-
dose DT (Kim et al., 2007). We found the elimination of maternal
Tregs beginning midgestation reversed the pregnancy-associ-
ated susceptibility to Lm infection (Figure 1B). This Treg-medi-
ated defect in host defense was not limited only to Lm, because
susceptibility to Salmonella typhimurium (ST) during pregnancy
was similarly reversed by the ablation of maternal Foxp3+ cells
(Pejcic-Karapetrovic et al., 2007) (Figure 1C). Together, these
results indicate maternal Foxp3+ Tregs contribute to preg-
nancy-associated infection susceptibility.
Foxp3+ Tregs Impair Host Defense against Infection
Given the expansion of fetal tissue that occurs in parallel with
maternal Foxp3+ Tregs, infection susceptibility during pregnancy
may also reflect more target tissue susceptible to direct invasion
by Listeria and Salmonella species (Bakardjiev et al., 2006; Le
Monnier et al., 2007; Pejcic-Karapetrovic et al., 2007). In agree-
ment, we found Lm infection midgestation caused dose-depen-
dent increased rates of fetal invasion (see Figure S1 available on-
line). Moreover, since the products of conception are
not resorbed immediately after Foxp3+ cell ablation, the precise
impacts of expanded Tregs on infection susceptibility cannot be
investigated exclusively using pregnant mice. Accordingly, to
more definitively interrogate the impacts of Foxp3+ Tregs on
host defense, we compared infection susceptibility ofell Host & Microbe 10, 54–64, July 21, 2011 ª2011 Elsevier Inc. 55
Figure 1. Expanded Maternal Foxp3+ Tregs Dictate Infection Susceptibility during Pregnancy
(A) Percent and total number Foxp3+ among CD4+ splenocytes in male, virgin female, or pregnant B6 (H-2b) females at midgestation after allogeneic mating with
Balb/c (H-2d) or syngeneic mating with B6 males.
(B and C) Recoverable CFUs 3 days after infection in nonpregnant, pregnant Treg-sufficient, or pregnant Treg-abated Foxp3DTR/DTR females after allogeneic
mating, and initiated on DT beginning midgestation and infected with Listeria monocytogenes (B) or Salmonella typhimurium (C) 1 day later.
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Expanded Tregs Dictate Susceptibility to Infectionnonpregnant mice after Treg manipulation using complementary
gain- and loss-of-function approaches.
Foxp3 expression in T cells is stimulated by STAT5b promoter
binding, and mice containing a constitutively active isoform of
STAT5b (CA-STAT5b) have expanded Foxp3+ Tregs (Burchill
et al., 2003) (Figure 2A, Figure S2). Consistent with the notion
that expanded Tregs promote infection susceptibility, signifi-
cantly more recoverable CFUs were found in CA-STAT5b
compared with B6 control mice after Lm infection (Figure 2B).
Since aberrations in other immune cells (e.g., CD8+ T and
CD19+ B cells) in CA-STAT5b mice may also contribute to infec-
tion susceptibility, related experiments more specifically investi-
gated the contribution of expanded Foxp3+ Tregs in these mice.
First, CA-STAT5b mice were intercrossed with Foxp3DTR mice,
allowing for the ablation of expanded Foxp3+ Tregs with DT.
We found DT treatment in CA-STAT5b Foxp3DTR mice efficiently
ablated expanded Foxp3+ cells and restored resistance to levels
comparable to Treg unmanipulated controls (Figures 2A and 2B).
In turn, DT treatment in Foxp3DTR compared with Foxp3WT mice
also caused significant reductions in recoverable Lm CFUs,
congruent with the effects of Treg ablation on infection suscep-
tibility for pregnant mice. As a complementary approach, we ex-
ploited the efficiency whereby adoptively transferred Tregs not
susceptible to DT repopulate this ablated cell compartment
by using Tregs from CA-STAT5b or control mice to reconstitute
Treg-ablated Foxp3DTR mice sustained on low-dose DT. We
found Treg-ablated mice reconstituted with CA-STAT5b com-
pared with WT Tregs contained 2-fold increased Foxp3+ cells56 Cell Host & Microbe 10, 54–64, July 21, 2011 ª2011 Elsevier Inc.(23% compared with 11%) due to cell-intrinsic STAT5b stimula-
tion that drives Foxp3+ cell expansion (Figure 2C). Foxp3+ CD4+
cells in mice reconstituted with CA-STAT5b or WT Tregs were
each >99% donor derived, while <1% Foxp3 cells were donor
derived based on expression of the CD45.2 congenic marker.
After Lm infection, Treg-ablated Foxp3DTR mice reconstituted
with expanded CA-STAT5b compared with WT Tregs contained
significantly more recoverable CFUs that paralleled the
increased susceptibility of CA-STAT5b mice (Figure 2D). Thus,
expanded Foxp3+ Tregs impair host defense and confer suscep-
tibility to disseminated Lm infection.
Sustained Expansion of Maternal Foxp3+ Tregs
Is Required for Maintaining Pregnancy
The infection susceptibility associated with the physiological
expansion of maternal Foxp3+ cells during allogeneic pregnancy
suggests that the proposed role these cells play in facilitating
antigenic diversity is more important for species survival, out-
weighing transient defects in host defense against infection.
In this regard, although the importance of maternal Tregs dur-
ing pregnancy has been described using strategies that cause
the near-complete ablation of these cells based on CD25
expression (Aluvihare et al., 2004; Kahn and Baltimore, 2010),
the specific requirement for maternal Foxp3+ cells expanded
from steady-state levels found in nonpregnant controls in
maintaining pregnancy remains undefined. To investigate this
question, we exploited the X-linked inheritance of foxp3
where random chromosome inactivation in Foxp3DTR/WT
Figure 2. Expanded Foxp3+ Tregs Impair Host
Defense against Lm Infection
(A) Percent Foxp3+ among CD4+ splenocytes after DT
treatment in B6 (WT), Foxp3DTR, CA-STAT5b, or CA-
STAT5b Foxp3DTR mice.
(B) Recoverable CFUs 3 days after Lm infection for each
group of mice initiated on DT treatment 1 day prior to
infection.
(C) Percent Foxp3+ Tregs day 14 after the initiation of
sustained DT in Foxp3DTR CD45.1+ mice reconstituted
with donor Tregs (CD45.2+) from WT or CA-STAT5b mice
(top). CD45.2 expression by Foxp3+ (line) or Foxp3
(shaded) CD4+ T cells (bottom).
(D) Recoverable CFUs 3 days after Lm infection for the
mice described in (C).
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Expanded Tregs Dictate Susceptibility to Infectionheterozygous females results in distinct Foxp3DTR and Foxp3WT
Treg subsets. We found the initiation of DT beginning midgesta-
tion in Foxp3DTR/WT mice caused more modest (35%) reduc-
tions in Foxp3+ Tregs, compared with the expected 50%, that
closely approximates the level found in nonpregnant controls
(Figures 3A and 1A). Even with sustained DT, these reductions
were transient as Foxp3+ cells rapidly rebounded to levels found
in pregnant Foxp3WT/WT controls. These findings are each
consistent with the continuous refilling of this partially depleted
compartment with Foxp3WT Tregs that are not susceptible to
ablation in Foxp3DTR/WT mice (Kim et al., 2007). Interestingly,
these partial transient reductions in maternal Tregs achieved
with DT in Foxp3DTR/WT mice were nevertheless sufficient to
trigger sharply increased rates of fetal resorption (10-fold, p <
0.001) with reciprocal reductions in the number of live pups
born (70% reduction, p < 0.001) each compared with Treg-suffi-
cient pregnancies (Figures 3B and 3C). By extension, DT treat-
ment in pregnant Foxp3DTR/DTR mice caused the sustained
near-complete ablation of Tregs and more profound rates of
fetal resorption with reciprocal elimination of live pups born
(Figures 3A–3C).Cell Host & MicrobImportantly, these detrimental pregnancy
outcomes were not due to nonspecific effects
related to DT, because each group of mice
received the same dosing of this reagent begin-
ning midgestation; nor were they caused by
inherent defects in Foxp3DTR/DTR or Foxp3DTR/WT
mice, because without DT, the number of live
pups born for each was indistinguishable from
Treg-sufficient controls (Figure3C). Furthermore,
given the potential for DT-mediated ablation of
fetal Foxp3+ cells in Foxp3DTR pregnancies, we
examined Foxp3 expression in E10.5–E16.5
embryos using both anti-Foxp3 antibody and
Foxp3GFP reporter mice (Fontenot et al., 2005b).
In each method, no detectable Foxp3 expres-
sion in utero above background levels was
observed (Figure S3). The absence of in utero
Foxp3 expression is consistent with the birth of
males hemizygous for defects in Foxp3 at the ex-
pected Mendelian ratios (Brunkow et al., 2001),
the ability of donor Tregs adoptively transferred
after birth to rescue Foxp3-deficient mice fromsystemicautoimmunity (Fontenot et al., 2003), and the veryminus-
cule levels of Foxp3 expression in 1-day-old mice (Fontenot et al.,
2005a). Moreover, the observed rates of in utero fetal resorption
triggered by DT in Foxp3DTR/WT (57%) and Foxp3DTR/DTR (90%)
pregnancies significantly exceed the expected percentage of
Foxp3DTR pups after allogeneic mating with Foxp3WT/WT males.
Accordingly, the effects of DT treatment in Foxp3DTR/WT and
Foxp3DTR/DTR pregnancies most likely reflect the manipulation of
maternal and not fetal Tregs. Since the majority of expanded
Foxp3+ Tregs during pregnancy are also CD25+ (Figure 1A), these
results are consistentwith the importanceofCD25+CD4+Tcells in
maintainingpregnancy (Aluvihareet al., 2004;KahnandBaltimore,
2010). However, our use of reagents that manipulate Tregs based
on Foxp3 expression and cause the partial ablation of these cells
to prepregnancy levels more specifically establishes the impor-
tance of sustained maternal Treg expansion during pregnancy.
Expanded Maternal Tregs Sustain Tolerance
to Fetal Antigen
The requirement for sustained expansion of Foxp3+ cells during
pregnancy suggests these cells provide uninterrupted activee 10, 54–64, July 21, 2011 ª2011 Elsevier Inc. 57
Figure 4. Expanded Maternal Tregs Sustain Tolerance to Fetal
Antigen
(A) Percent and number of adoptively transferred CD90.1+ fetal-(OVA323-339)-
specific CD4+ (top) or (OVA257-264)-specific CD8
+ (bottom) cells among
splenocytes in Foxp3WT/WT, Foxp3DTR/DTR, or Foxp3DTR/WT females impreg-
nated by Actin-OVA transgenic males 5 days after the initiation of DT beginning
midgestation (E10.5).
(B) Percent and number of IFN-g-producing CD90.1+ CD8+ T cells after in vitro
OVA257-264 peptide stimulation (line) or unstimulated controls (shaded).
(C) Percent OVA257-264 peptide-pulsed (CFSE
lo) relative to untreated control
cells (CFSEhi) pretransfer, or after adoptive transfer into each group of females
impregnated by Actin-OVA males initiated on DT treatment beginning mid-
gestation.
Figure 3. Sustained Expansion ofMaternal Foxp3+ Tregs Is Required
for Maintaining Pregnancy
(A) Percent Foxp3+ among CD4+ splenocytes during allogeneic pregnancy in
Foxp3WT/WT, Foxp3DTR/WT, or Foxp3DTR/DTR mice after the initiation of DT
treatment beginning midgestation (E10.5). Scale bar, one standard error.
(B) Percent live or resorbed fetuses in individual pregnancies for each group of
mice day 5 after the initiation of DT beginning midgestation. Scale bar, mean
and 95% confidence interval.
(C) Number of live pups born after allogeneic mating for each group of female
mice either treated with DT for 4 consecutive days beginning midgestation
(filled) or without DT treatment (open).
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Expanded Tregs Dictate Susceptibility to Infectionimmune tolerance to the developing fetus. To investigate this
hypothesis, the impacts of Treg ablation on the priming and
activation of maternal T cells with specificity to the fetus were
enumerated. To more precisely track the response to fetal
antigen, we substituted mice where ovalbumin (OVA) is ex-
pressed in all cells on the Balb/c background for mating with
non-OVA-expressing females on the B6 background (Ehst
et al., 2003). This strategy allows T cells amongmaternal immune58 Cell Host & Microbe 10, 54–64, July 21, 2011 ª2011 Elsevier Inc.cells with specificity to defined peptides within the surrogate
fetal-(OVA) antigen to be tracked using well-characterized
immunological tools (Erlebacher et al., 2007). We found Treg
ablation beginning midgestation triggered similar increased
rates of fetal resorption in Foxp3DTR/WT (57%) and Foxp3DTR/DTR
(96%) pregnancies that was associated with robust expansion of
OVA-specific CD4+ andCD8+ T cells comparedwith Foxp3WT/WT
pregnancies (Figure 4A). Importantly, the expansion of these
OVA-specific T cells was specific to the developing fetus and
not caused by nonspecific effects related to Foxp3+ cell manip-
ulation, because only background levels were found in Treg-
ablated females impregnated with non-OVA-expressing males
(Figure S4). Furthermore, maternal Tregs also suppress the
activation of fetal-(OVA)-specific T cells because CD8+ T cells
Figure 5. Treg-Mediated Infection Suscep-
tibility Requires Cell-Intrinsic IL-10
(A) Percent Foxp3+ among CD4+ splenocytes day
10 after the initiation of sustained DT in irradiated
Foxp3DTR CD45.1+ mice without donor bone
marrow, or reconstituted with bone marrow from
WT, IL-10-deficient, CTLA-4-deficient mice, or
mice with combined defects in both IL-10 and
CTLA-4 (DKO) (top). CD45.2 expression by Foxp3+
(line) or Foxp3 (shaded) CD4+ cells (bottom).
(B) Recoverable CFUs 3 days after Lm infection for
the mice described in (A).
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Expanded Tregs Dictate Susceptibility to Infectionfrom pregnancies with partial (Foxp3DTR/WT) or near-complete
(Foxp3DTR/DTR) Treg ablation produce significantly more IFN-g
after OVA257-264 peptide stimulation, and eliminated adoptively
transferred OVA257-264 peptide-coated target cells more effi-
ciently, compared with Treg-sufficient (Foxp3WT/WT) pregnan-
cies (Figures 4B and 4C). Thus, fetal resorption and fractured
tolerance to fetal antigen triggered by even partial reductions
in maternal Foxp3+ Tregs in mice recapitulates human preg-
nancy complications related to fetal intolerance (e.g., sponta-
neous abortion, preeclampsia) each associated with blunted
expansion of maternal Tregs (Prins et al., 2009; Santner-Nanan
et al., 2009; Sasaki et al., 2004).
TregCell-Intrinsic IL-10Confers Infection Susceptibility
Given the divergent roles for expanded maternal Tregs that are
on one hand required for sustaining pregnancy, but also impair
host defense that confers infection susceptibility, we explored
if targeted ablation of individual Treg-associated molecules
would allow these protective and harmful effects to be dissoci-
ated. In this regard, although numerous Treg-associated mole-
cules that can each mediate immune suppression in vitro have
been identified (Sakaguchi et al., 2009; Shevach, 2009; Vignali
et al., 2008), the relative importance for each in dictating the
multifaceted role Foxp3+ cells play in vivo remains incompletely
defined. We focused initially on CTLA-4 and IL-10 because each
plays a dominant role for Treg suppression in other in vivo
contexts (Asseman et al., 1999; Belkaid et al., 2002; Friedline
et al., 2009; Rubtsov et al., 2008; Wing et al., 2008). To evaluate
the requirement for Treg expression of each molecule, bone
marrow cells from CTLA-4-deficient, IL-10-deficient, or WT
mice were adoptively transferred into sublethally irradiatedCell Host & Microbe 10, 5Foxp3DTR CD45.1+ recipient mice. After
reconstitution and before DT treatment,
these mixed chimera mice contain Tregs
with targeted defects in either CTLA-4
or IL-10, each derived from donor bone
marrow cells and WT Tregs from
Foxp3DTR recipient mice. However, after
DT treatment, Tregs derived from recip-
ient Foxp3DTR mice are eliminated,
leaving behind only those derived from
donor CD45.2+ bone marrow cells that
rapidly expand to refill this partially
ablated compartment (Figure 5A). Using
this approach that allows the moresynchronized ablation of each Treg-associated molecule, mice
containing only CTLA-4-deficient compared with WT Tregs
were found to have expanded Foxp3+ cells consistent with the
role of CTLA-4 in limiting Treg proliferation (Kolar et al., 2009;
Tang et al., 2008). In turn, mice with expanded CTLA-4-deficient
compared with WT Tregs were also more susceptible to Lm
infection (Figure 5B). Comparatively, while IL-10-deficient and
WT Tregs each expand to a similar extent in irradiated Foxp3DTR
mice, those containing only IL-10-deficient Tregs compared with
mice containing eitherWT or CTLA-4-deficient Tregs weremark-
edly more resistant to Lm infection (Figures 5A and 5B).
To further investigate the requirement for IL-10 and CTLA-4
expression by Tregs in host defense against infection, mixed
chimera mice containing Foxp3+ cells with targeted defects in
both molecules were generated by using bone marrow cells
from mice with combined defects in both IL-10 and CTLA-4
(DKO) for reconstituting sublethally irradiated Foxp3DTR mice.
Although the rate of recombination between these two genes
separated by 39.8 cM on chromosome 1 was somewhat lower
than expected (Figure S5A), mice with defects in both IL-10
and CTLA-4 could be generated, and began to appear runty
with a ‘‘scurfy’’ phenotype beginning at 23–27 days of life that
was indistinguishable from CTLA-4-deficient mice (Tivol et al.,
1995; Waterhouse et al., 1995). After adoptive transfer into irra-
diated Foxp3DTR mice, bone marrow cells from these DKO
mice led to expanded levels of Foxp3+ Tregs comparable to
reconstitution with bone marrow from CTLA-4-deficient mice
(Figure 5A). However, despite the expansion of Foxp3+ Tregs
due to cell-intrinsic defects in CTLA-4, these mice were more
resistant to Lm infection with significantly reduced CFUs com-
pared with mice containing CTLA-4-deficient (IL-10-sufficient)4–64, July 21, 2011 ª2011 Elsevier Inc. 59
Figure 6. Treg IL-10 Impairs Resistance against Lm Infection
(A) Percent Foxp3+ among CD4+ splenocytes day 12 after the initiation of
sustained DT in nonirradiated Foxp3DTR CD45.1+ mice without donor Tregs, or
reconstituted with donor Tregs from WT or IL-10-deficient mice (top). CD45.2
expression by Foxp3+ (line) or Foxp3 (shaded) CD4+ cells (bottom).
(B) Recoverable CFUs 3 days after Lm infection for the mice described in (A).
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Expanded Tregs Dictate Susceptibility to InfectionTregs (Figure 5B). Importantly, these impacts on infection
susceptibility are not explained by potential differences in
nonspecific immune activation, because donor bone marrow-
derived Tregs from each group of mice compared with Treg-
ablated mice without donor bone marrow suppressed activation
(percent CD44hiCD62Llo) among bulk T cells to the same extent
(Figure S5B). Together, these results indicate that while CTLA-4
controls host defense against Lm indirectly by limiting Treg
expansion, ablation of IL-10 overrides the infection susceptibility
associated with both expanded CTLA-4-deficient and normal
levels of WT Tregs.
Related experiments sought to investigate whether resistance
against Lm infection in mice containing exclusively IL-10-defi-
cient Tregs could be attributed to the mixed population of WT
and IL-10-deficient non-Treg cells derived from donor bone
marrow in irradiated Foxp3DTR mice. Donor Tregs from IL-10-
deficient or B6 control mice were used to repopulate nonirradi-
ated Foxp3 cell-ablated Foxp3DTR mice, and with sustained DT
for 7–10 days, >99% of Foxp3+ Tregs and <1% non-Tregs
were donor derived based on CD45.2 expression (Figure 6A).
After Lm infection, mice reconstituted with IL-10-deficient
compared with WT Tregs were more resistant, containing signif-
icantly reduced numbers of recoverable CFUs (Figure 6B).
Similar to reconstituted Tregs in irradiated mice, adoptively
transferred IL-10 and WT Tregs each suppressed nonspecific60 Cell Host & Microbe 10, 54–64, July 21, 2011 ª2011 Elsevier Inc.T cell activation to a similar extent compared with Treg-ablated
mice without donor cells (Figure S6). Taken together, these
results demonstrate a critical role for Foxp3+ Tregs and IL-10
production by these cells in suppressing host defense against
Lm infection.
IL-10 Is Dispensable for Sustaining Pregnancy
but Impairs Host Defense against Prenatal Infection
Given the requirement for maternal Foxp3+ Tregs in sustaining
pregnancy, we examined whether parallel requirements exist
for maternal IL-10 by enumerating pregnancy outcomes in
IL-10-deficient compared with B6 control mice after allogeneic
mating with Balb/c males. In sharp contrast to pregnancy loss
that occurs with even partial transient Treg ablation, IL-10-defi-
cient compared with IL-10-sufficient pregnancies had indistin-
guishable normal numbers of live pups born at term (Figure 7A).
The nonessential role for maternal IL-10 in sustaining allogeneic
pregnancy together with the importance of Treg IL-10 in
promoting susceptibility to Lm infection suggests IL-10 neutral-
ization may be used for boosting immunity against infection
without compromising pregnancy outcomes. Consistent with
this hypothesis, we found pregnant IL-10-deficient compared
with pregnant B6 controls were significantly less susceptible to
Lm infection (Figure 7B). These results are in agreement with
the increased resistance against Lm for IL-10-deficient nonpreg-
nant mice (Dai et al., 1997), and extend the importance of this
cytokine to infection susceptibility during pregnancy. As a
complementary approach, we enumerated the impacts of
IL-10 receptor neutralization on pregnancy outcomes and resis-
tance to Lm infection. Similar to findings using IL-10-deficient
mice, anti-IL-10 receptor compared with isotype control anti-
body treatment at midgestation had no significant impacts on
the number of live births after allogeneic pregnancy but caused
sharp reductions in the number of recoverable Lm CFUs after
infection (Figures 7C and 7D). Together, these results establish
that although IL-10 is dispensable for sustaining pregnancy, it
impairs host defense against prenatal Lm infection.
DISCUSSION
Regulatory T cells control the fluid balance between immune
suppression that maintains peripheral tolerance and immune
stimulation required for optimal host defense against infection.
Herein, we demonstrate that pregnancy triggers the physiolog-
ical expansion of Foxp3+ Tregs that shifts this balance, allowing
maternal tolerance to the developing fetus to be maintained.
Using tools that manipulate Tregs based on Foxp3 expression
and cause the partial ablation of these cells, the blunted expan-
sion of maternal Tregs observed in human pregnancy complica-
tions such as spontaneous abortion or preeclampsia where
these cells are reduced to prepregnancy levels, but not
completely eliminated, is more closely recapitulated (Prins
et al., 2009; Santner-Nanan et al., 2009; Sasaki et al., 2004).
We find the sustained expansion of Foxp3+ Tregs was imperative
because even transient partial ablation to levels found in
nonpregnant mice was sufficient to cause sharply increased
rates of fetal resorption, reductions in the number of live pups
born, and the expansion and activation of maternal T cells with
specificity to the fetus. Given the parallel requirements for
Figure 7. Maternal IL-10 Is Dispensable for
Sustaining Pregnancy but Impairs Host
Defense against Prenatal Lm Infection
(A) Number of live pups born for IL-10-deficient or
B6 (WT) mice after allogeneic mating with Balb/c
males.
(B) Recoverable CFUs 3 days after Lm infection at
midgestation (E10.5) for IL-10-deficient or B6 (WT)
pregnant mice.
(C) Number of live pups born for B6 mice after
allogeneic mating with Balb/c males treated with
anti-IL-10 receptor or isotype control (rat IgG1)
antibody beginning midgestation.
(D) Recoverable CFUs in pregnant B6 mice 3 days
after Lm infection and treatment with anti-IL-10
receptor or isotype control antibody at mid-
gestation.
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(IDO) in sustaining pregnancy, and the potency whereby Tregs
stimulate tryptophan catabolism (Fallarino et al., 2003; Munn
et al., 1998), blunted expansion or transient ablation of maternal
Tregs may complicate pregnancy by disrupting this pathway.
This is consistent with the upregulation of IDO during uncompli-
cated human pregnancy compared with spontaneous abortion
cases (Miwa et al., 2005). Our ongoing studies are aimed at dis-
secting themolecular basis for howmaternal Tregs sustain preg-
nancy and the pregnancy-associated signals that drive the
expansion of maternal Tregs. In this regard, while maternal Tregs
suppress IFN-g production by fetal-specific T cells and IFN-g is
a potent inducer of IDO expression (Taylor and Feng, 1991), IFN-
g responsiveness was nonessential for Treg expansion, illus-
trating that other unidentified signals stimulate shifts in maternal
Foxp3+ cells during allogeneic pregnancy.
The physiological expansion of Tregs during pregnancy and
non-antigen-specific fashion whereby these cells mediate
suppression suggest other detrimental or potentially protective
immune responses may be suppressed as well. For example,
for patients with rheumatoid arthritis or autoimmune hepatitis,
reduction in disease severity or disease remission occurs during
pregnancy (Buchel et al., 2002; Ostensen and Villiger, 2007). On
the other hand, given the intricately regulated balance between
immune stimulation and suppression, sustained expansion of
immune tolerance during pregnancy may also cause defects in
host defense, especially against pathogens such as Listeria
monocytogenes and Salmonella typhimurium with a predilection
for prenatal infection (Gellin et al., 1991; Mylonakis et al., 2002;
Pejcic-Karapetrovic et al., 2007). Accordingly, we investigated
the impacts of expanded Tregs on infection susceptibility in
complementary in vivo models that include allogeneic preg-
nancy, CA-STAT5b transgenicmice, andmicewith Treg-intrinsicCell Host & Microbe 10, 5defects in CTLA-4. In each condition
where Tregs are expanded, increased
infection susceptibility was uniformly
identified. Furthermore, in each model of
expanded Tregs where host defense
against infection is impaired, secondary
defects that include the ablation of
expanded Tregs or specific Treg-intrinsicmolecules were used to confirm the overall importance of
Tregs, or to identify Treg-associated molecules that mediate
infection susceptibility. Although our experiments were not de-
signed to evaluate the additional incremental impacts whereby
direct invasion into the products of conception causes suscepti-
bility to disseminated Lm infection (Bakardjiev et al., 2006;
Le Monnier et al., 2007), the direct links between Tregs manipu-
lated using these complementary gain- and loss-of-function
approaches in pregnant and nonpregnant mice on susceptibility
to Lm infection establish that expanded Tregs required for
sustaining pregnancy also impair host defense against this
important prenatal pathogen. These findings suggest the
expansion of maternal Tregs that facilitates increased genetic
diversity between maternal and paternal antigen is more impor-
tant for species survival outweighing transient defects in host
defense.
The deleterious impact of expanded Tregs on host defense
against Lm is consistent with the accelerated pathogen eradica-
tion caused by ablation of CD25+ or Foxp3+ Tregs during infec-
tion with an increasingly wide assortment of other pathogens
(Belkaid, 2007; Johanns et al., 2010; Suvas and Rouse, 2006).
However, while prior studies have primarily used loss-of-function
approaches for investigating the role of Tregs in host defense,
this study uses complementary approaches that mimic the phys-
iological prenatal expansion of these cells to demonstrate how
increased Foxp3+ Tregs dictates infection susceptibility during
pregnancy. An important area for future investigation is to
explore if similar impacts on host defense are found after infec-
tion with other pathogens using gain-of-function approaches for
Foxp3+ Tregs. In this regard, although the number of pathogens
where Tregs have been implicated to suppress host defense
far exceeds the limited number with defined predilection for
prenatal infection, the results of these studies will likely have4–64, July 21, 2011 ª2011 Elsevier Inc. 61
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aging and other contexts where the physiological expansion of
Tregs also occurs (Gregg et al., 2005).
Numerous Foxp3+ cell-associated molecules have been
shown to mediate the suppressive properties of Tregs (Sakagu-
chi et al., 2009; Shevach, 2009; Vignali et al., 2008). Recently,
intercrossing mice in which the Cre-recombinase and foxp3
are coexpressed with other mice where each Treg-associated
molecule of interest is flanked by loxP sites has revealed unique
and discordant roles for defined Treg-associated molecules in
controlling specific aspects of peripheral tolerance (Rubtsov
et al., 2008; Wing et al., 2008). Although ideal for identifying
Treg-associated molecules that with sustained ablation cause
autoimmunity, this strategy that results in the ablation of each
molecule in Foxp3+ cells throughout development is not suitable
for interrogating their role in host defense against infection
where the synchronized ablation of each molecule in Tregs is
required. Accordingly, for interrogating the relative importance
of Treg-associated molecules in controlling host defense against
Lm infection, we exploited the efficiency whereby donor Tregs
from mice with targeted defects in each Treg-associated
suppression molecule expand to fill the partially ablated cellular
compartment in mixed chimera mice, or the completely empty
compartment in Treg-ablated mice. These approaches that
allow more synchronized ablation of specific Treg-associated
molecules in Foxp3+ cells identified important roles for Treg
IL-10 in suppressing host defense against Lm infection. Interest-
ingly, however, elimination of Treg IL-10 in neither nonirradiated
Treg-reconstituted mice nor irradiated mice containing ex-
panded CTLA-4-deficient Tregs restored resistance to levels
found in Treg-ablated mice. These findings indicate that other
Treg-associated molecules likely play functionally redundant
roles and/or act synergistically with IL-10 in impairing host
defense against Lm infection.
The importance of IL-10 in suppressing immunity against Lm
infection during pregnancy is in agreement with the previously
reported importance of this cytokine in promoting susceptibility
to other pathogens (Belkaid et al., 2002; Brooks et al., 2006;
Ejrnaes et al., 2006). Together with controlling inflammation at
mucosal surfaces (Asseman et al., 1999; Rubtsov et al., 2008),
our results extend the context-specific role of Treg IL-10 to
include suppressing host defense components after acute path-
ogenic infection during pregnancy. Given the nonessential roles
for maternal IL-10 inmaintaining pregnancy even after allogeneic
mating, these results demonstrate that IL-10 can dissociate the
detrimental impacts of expanded Tregs on infection suscepti-
bility from the beneficial effects required for sustaining preg-
nancy. Accordingly, it is tantalizing to consider that the benefits
of transiently neutralizing IL-10 for boosting host defense during
complicated prenatal infections would not be harmful for preg-
nancy, and may therefore outweigh the potentially detrimental
impacts on peripheral tolerance.
EXPERIMENTAL PROCEDURES
Mice
B6, Balb/c, SJL CD45.1+, IL-10-deficient (Kuhn et al., 1993), and IFN-g
receptor-deficient (Huang et al., 1993) mice were each purchased from The
Jackson Laboratory. Foxp3DTR and Foxp3GFP mice were generously provided
by Dr. Alexander Rudensky (Fontenot et al., 2005b; Kim et al., 2007).62 Cell Host & Microbe 10, 54–64, July 21, 2011 ª2011 Elsevier Inc.Foxp3DTR mice were backcrossed >15 generations to B6 mice and inter-
crossed with CD45.1+ mice. Actin-OVA mice (Ehst et al., 2003) were back-
crossed >10 generations to Balb/c mice. OT-1 and OT-II TCR transgenic
mice were maintained on a Rag1-deficient CD90.1 (B6) background. CA-
STAT5b mice (Burchill et al., 2003) were intercrossed with Foxp3DTR mice
to generate CA-STAT5b Foxp3DTR mice. CTLA-4-deficient mice have been
described (Tivol et al., 1995; Waterhouse et al., 1995). Mice with combined
defects in IL-10 and CTLA-4 were generated by intercrossing mice with indi-
vidual defects (Figure S5). For Treg ablation, mice were treated with an initial
dose of DT (25 mg/kg) followed by subsequent daily doses of 5 mg/kg. All
experiments were performed using University of Minnesota IACUC-approved
protocols.
Antibodies and Flow Cytometry
Fluorophore-conjugated antibodies and other reagents for cell surface, intra-
cellular, and intranuclear staining were purchased from eBioscience or BD
Biosciences. Intracellular cytokine staining was performed for bulk ex vivo
splenocytes (containing OVA-specific CD8+ T cells and antigen-presenting
cells) after stimulation with OVA257-264 peptide or no stimulation control in
media containing GolgiPlug (BD Biosciences). Antibodies for IL-10 receptor
neutralization (1B1.3A) (Brooks et al., 2006; Ejrnaes et al., 2006) and rat IgG1
isotype control were purchased from BioXcell and inoculated intraperitoneally
(1 mg/mouse) into pregnant mice at midgestation.
Cell Transfers
Purified CD8+ T cells (105) fromOT-I or CD4+ T cells (106) fromOT-II TCR trans-
genic mice were adoptively transferred into Foxp3WT/WT, Foxp3DTR/DTR, or
Foxp3DTR/WT females impregnated with Actin-OVA or non-OVA-expressing
Balb/c males at mid-gestation (E10.5) with the initiation of DT. To measure
cytotoxicity, splenocytes from congenic (CD45.2+) mice were stained with
either high (1 mM) or low (50 nM) CFSE, pulsed with OVA257-264 peptide
(50 nM CFSE) or no peptide control (1 mM CFSE), mixed at a 1:1 ratio, adop-
tively transferred into pregnant mice 4 days after the initiation of DT at mid-
gestation, and harvested 8 hr after transfer.
Infections
Lm strain 10403s (Portnoy et al., 1988) and ST strain SL1344 (Johanns et al.,
2010) were each grown to early log phase (OD600 0.1) in brain heart infusion
media at 37C, washed and diluted with saline to 200 ml, and injected intra-
venously (5 3 103 CFUs for Lm, and 1 3 102 CFUs for ST). For enumerating
susceptibility, the number of recoverable bacteria in the spleen or liver
3 days after infection was quantified by organ homogenization and plating
serial dilutions onto agar plates as described (Rowe et al., 2008). For enumer-
ating fetal invasion, each placental fetal unit was individually dissected,
homogenized in saline, and cultured on agar plates.
Bone Marrow Chimera and Treg Reconstitutions
Bone marrow cells were harvested from the tibias and femurs from donor
mice, intravenously transferred into sublethally irradiated (725 rads) Foxp3DTR
mice, and allowed to reconstitute for 8–10 weeks. Thereafter, mice were
treatedwith DT for 10 days, then infectedwith Lm to evaluate infection suscep-
tibility. For reconstituting Foxp3+ cells in nonirradiated Foxp3DTR mice, donor
Tregs from B6, CA-STAT5b, or IL-10-deficient mice were adoptively trans-
ferred into Foxp3DTR mice (5 3 105 donor Foxp3+ CD4+ cells per mouse)
with the initiation of daily DT, and infected with Lm 15 days later.
Statistical Analysis
The number and percent of live pups, resorbed concepti, cell numbers, and
recoverable log10 bacterial CFUs were first analyzed and found to be normally
distributed. Thereafter, differences between each group were analyzed using
the unpaired Student’s t test (Prism, GraphPad) with p < 0.05 taken as statis-
tical significance.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at doi:10.1016/j.chom.2011.06.005.
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